Viracta Therapeutics (VIRX) 10-K2016 FY Annual report

Filed: 9 Mar 17, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: abuse, Alliance, AQD, attain, attribution, bear, bond, burden, checkpoint, chemotherapeutic, CMS, complicating, condensed, constrain, covenant, diagnosed, DOJ, EHA, embedded, encumbrance, export, flow, footnote, Frontline, geoffrey, host, imposition, Infusional, irreversible, Justice, LIBOR, LOI, lot, marginal, mutate, mutation, nivolumab, parker, passage, PD, pharmacodynamic, pharmacology, PK, preempted, prepay, progression, purity, put, recall, referral, representation, residue, resolution, responded, restitution, retroactive, revocation, sequence, serine, slightly, Solar, split, step, Task, Topic, Trump, untitled, Vanderbilt, VITAL, warranty, withholding, zone

Removed: acceleration, accurately, attestation, borrow, built, commitment, COSO, cured, declare, detect, detection, disposition, drew, DSMB, Ernst, expressed, foreclosure, formation, formulated, franchise, helen, hydrate, inadequate, incurrence, ingredient, input, Integrated, kim, lender, LLP, minimize, ORR, packaged, particle, perfection, pertain, registration, territory, thereon, tranche, unblinding, understanding, unqualified, vial, visible, weighing

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

VIRX similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the following Registration Statements:

(1)

Registration Statement (Form S-3 No. 333-168191) of Sunesis Pharmaceuticals, Inc.,

(2)

Registration Statement (Form S-3 No. 333-187854) of Sunesis Pharmaceuticals, Inc.,

(3)

Registration Statement (Form S-3 No. 333-194166) of Sunesis Pharmaceuticals, Inc.,

(4)

Registration Statement (Form S-3 No. 333-195779) of Sunesis Pharmaceuticals, Inc.,

(5)

Registration Statement (Form S-8 No. 333-128647) pertaining to the 1998 Stock Plan, the 2001 Stock Plan, the 2005 Equity Incentive Award Plan and the Employee Stock Purchase Plan of Sunesis Pharmaceuticals, Inc.,

(6)

Registration Statement (Form S-8 No. 333-132679) pertaining to the 2006 Employment Commencement Incentive Plan of Sunesis Pharmaceuticals, Inc.,

(7)

Registration Statement (Form S-8 No. 333-138758) pertaining to the 2001 Stock Plan, the 2005 Equity Incentive Award Plan and the Employee Stock Purchase Plan of Sunesis Pharmaceuticals, Inc.,

(8)

Registration Statement (Form S-8 No. 333-145404) pertaining to the 2005 Equity Incentive Award Plan, the Amended and Restated 2006 Employment Commencement Incentive Plan and the Employee Stock Purchase Plan of Sunesis Pharmaceuticals, Inc.,

(9)

Registration Statement (Form S-8 No. 333-150834) pertaining to the 2005 Equity Incentive Award Plan, the Amended and Restated 2006 Employment Commencement Incentive Plan and the Employee Stock Purchase Plan of Sunesis Pharmaceuticals, Inc.,

(10)

Registration Statement (Form S-8 No. 333-160528) pertaining to the 2005 Equity Incentive Award Plan and the Amended and Restated 2006 Employment Commencement Incentive Plan of Sunesis Pharmaceuticals, Inc.,

(11)

Registration Statement (Form S-8 No. 333-174732) pertaining to the 2011 Equity Incentive Plan and the 2011 Employee Stock Purchase Plan of Sunesis Pharmaceuticals, Inc.,

(12)

Registration Statement (Form S-8 No. 333-180101) pertaining to the 2011 Equity Incentive Plan of Sunesis Pharmaceuticals, Inc.,

(13)

Registration Statement (Form S-8 No. 333-187234) pertaining to the 2011 Equity Incentive Plan of Sunesis Pharmaceuticals, Inc.,

(14)

Registration Statement (Form S-8 No. 333-195781) pertaining to the 2011 Equity Incentive Plan and the 2011 Employee Stock Purchase Plan of Sunesis Pharmaceuticals, Inc.,

(15)

Registration Statement (Form S-8 No. 333-202696) pertaining to the 2011 Equity Incentive Plan and the 2011 Employee Stock Purchase Plan of Sunesis Pharmaceuticals, Inc., and

(16)

Registration Statement (Form S-8 No. 333-210183) pertaining to the 2011 Equity Incentive Plan of Sunesis Pharmaceuticals, Inc.

of our report dated March 9, 2017, with respect to the consolidated financial statements of Sunesis Pharmaceuticals, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2016.

/s/ ERNST & YOUNG LLP

Redwood City, California

March 9, 2017

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.